Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America News Hub.
Press releases published on September 2, 2025
Lyno AI Presale Surpasses 390,000 Tokens Sold—Next Stage Price Jumps to $0.055 Soon
GlobeNewswire
·
September 2, 2025
ROAD TOWN, British Virgin Islands, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The presale by Lyno AI is getting a very strong traction, selling over 394,000 tokens and almost 20,000 dollars at the early bird price of 0.05 a token. Investors are scurrying to buy …
Globex Consolidates 100% Ownership of Blackcliff Gold Zone
GlobeNewswire
·
September 2, 2025
ROUYN-NORANDA, Quebec, Sept. 02, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …
Kallpa Generación S.A. Announces the Commencement of a Cash Tender Offer for any and all of its 4.125% Senior Notes due 2027
GlobeNewswire
·
September 2, 2025
LIMA, Peru, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Kallpa Generación S.A., a sociedad anónima incorporated under the laws of Peru (the “Company”) today announced that it has commenced a cash tender offer (the “Offer”) for any and all of its outstanding 4.125% …
Outlook Therapeutics Requests Type A Meeting with FDA
GlobeNewswire
·
September 2, 2025
ISELIN, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today announced that a Type A Meeting …
Taseko to Participate in the Jefferies 2025 Industrials Conference
GlobeNewswire
·
September 2, 2025
VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) (“Taseko” or the "Company") is pleased to announce its participation in the upcoming Jefferies 2025 Industrials Conference to be …
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
GlobeNewswire
·
September 2, 2025
SEATTLE and VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences
GlobeNewswire
·
September 2, 2025
SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today …
GDEV announces results for the second quarter and first half of 2025
GlobeNewswire
·
September 2, 2025
LIMASSOL, Cyprus, Sept. 02, 2025 (GLOBE NEWSWIRE) -- GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”), released its financial and operational results for the second quarter and first half-year ended June …
Bitget to Transfer 440 Million BGB to Morph Foundation, Accelerating BGB as Gas and Governance Token of Morph Chain
GlobeNewswire
·
September 2, 2025
Key Highlights Bitget will transfer all BGB tokens that it controls, 440 million in total, to the Morph Foundation, with 220 million burned immediately and the remaining 220 million locked with gradual release to support ecosystem growth. The Morph …
Camposol Holding PLC reports Preliminary Second Quarter and First Half 2025 Results.
GlobeNewswire
·
September 2, 2025
LIMA, Peru, September 2, 2025 -- Camposol Holding PLC (Camposol or the Company), a multinational company providing fresh and healthy food globally, today announced its preliminary financial results for the second quarter ended June 30, 2025. These results …
Lisata Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
BASKING RIDGE, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …
Clene to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
SALT LAKE CITY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the …
PDS Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
PRINCETON, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Integral Metals Announces Completion of 2025 Drilling at the KAP Project
GlobeNewswire
·
September 2, 2025
CALGARY, Alberta, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce the successful completion of its 2025 diamond drilling program at the flagship KAP Project …
Nasus Pharma Announces Upcoming Presentation at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
TEL AVIV, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical …
Replimune Announces Type A Meeting Scheduled with FDA
GlobeNewswire
·
September 2, 2025
WOBURN, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that a Type A meeting with the U.S. Food and Drug …
Critical Metals Corp NASDAQ CRML – Surpasses 70% Completion Milestone of the Tanbreez Bankable Feasibility Study & Remains on Schedule for Completion on or Before Q4 2025
GlobeNewswire
·
September 2, 2025
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced that Tanbreez Mining Greenland A/S (“Tanbreez”) is approximately 70% …
GDEV Strengthens Strategic Partnership with Royal Ark as Zombie Miner Reaches TOP-1 Position in its Genre
GlobeNewswire
·
September 2, 2025
LIMASSOL, Cyprus, Sept. 02, 2025 (GLOBE NEWSWIRE) -- GDEV Inc. (Nasdaq: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”), today announced that it has increased its total ownership in its portfolio studio, Royal Ark, to 57% …
Suzano announces cash tender offers for notes due 2026 and 2027
GlobeNewswire
·
September 2, 2025
SÃO PAULO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Suzano International Finance B.V. (“Suzano International Finance”) and Suzano Austria GmbH (“Suzano Austria”), each a wholly-owned subsidiary of Suzano S.A. (“Suzano”), announce the commencement of offers to …
BridgeBio to Present Phase 2 Proof-of-Concept Data for Encaleret in Post-Surgical Hypoparathyroidism
GlobeNewswire
·
September 2, 2025
PALO ALTO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that an oral presentation of Phase 2 data in …